The Haleon Group's actual results of operations, financial condition and the development of the business sectors in which the Haleon Group operates may differ materially from those expressed or implied in any forward-looking statement contained in this announcement due to certain factors including, but not limited to, domestic and global economic and business conditions, market-related risks pertaining to the consumer healthcare industry as a whole, the policies and actions of regulatory authorities, geopolitical developments, market developments, the impact of competition, technological development, inflation, deflation, foreign currency exchange rates, the timing, impact and other uncertainties of any future acquisitions, combinations or divestments within relevant industries, as well as the impact of tax and other legislation and other regulations in the jurisdictions in which the Haleon Group operates
People using insulin or sulfonylureas may have additional hypoglycemia concerns if future treatment affects food intake or glucose levels
Start by asking your healthcare provider whether drinking is appropriate for you
Este artculo examina la relacin entre los medicamentos GLP-1 y los niveles de energa, explorando los mecanismos indirectos, efectos secundarios relevantes y factores individuales que influyen en cmo te sientes durante el tratamiento
See additional terms and conditions for Chegg Study or Chegg Study Pack on Chegg.com Show transcribed image text Question: 13
